n/a
Abstract Title:

In Vitro and In Vivo Antiangiogenic Activity of Crowberry (Empetrum nigrum var. japonicum).

Abstract Source:

Nat Prod Commun. 2016 Apr ;11(4):503-6. PMID: 27396205

Abstract Author(s):

Hong-Sook Bae, Hyun Ju Kim, Da Hye Jeong, Takahiro Hosoya, Shigenori Kumazawa, Mira Jun, Oh-Yoen Kim, Sun Wook Kim, Mok-Ryeon Ahn

Article Affiliation:

Hong-Sook Bae

Abstract:

Crowberry, Empetrum nigrum var. japonicum, is widely used in folk medicine and grows naturally in Korea. Although some constituents and biological activity of Korean crowberry have been examined, there is little detailed information available. In this study, we investigated the effects of ethanol extracts of crowberry (EECB) on the inhibition of angiogenesis, both in vitro and in vivo. The effects of EECB were tested on in vitro models of angiogenesis, that is, tube formation and proliferation of human umbilical vein endothelial cells (HUVECs). EECB exhibited significant inhibitory effects on tube formation of HUVECs in a concentration-dependent manner. In addition, crowberry significantly suppressed the proliferation of HUVECs in a concentration-dependent manner. Furthermore, strong antiangiogenic activity of EECB samples was observed in the in vivo assay using chick embryo chorioallantoic membrane (CAM). These results indicate that crowberry may have potential applications in the prevention and treatment of angiogenesis-dependent human diseases.

Study Type : Animal Study, In Vitro Study
Additional Links
Pharmacological Actions : Anti-Angiogenic : CK(347) : AC(272)

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.